Skip to main content
logo
Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
85.12
+2.40 (2.90%)
Aug 4, 2026, 12:13 PM EDT - Market open

Inhibrx Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,2491,1522231,8001,0731,703
Market Cap Growth
299.39%416.59%-87.61%67.69%-36.96%36.95%
Enterprise Value
1,2331,13478.381,7321,0071,649
Last Close Price
85.1279.0015.4038.0024.6443.67

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--0.14---
Forward PE
-0.200.20---
PS Ratio
933.54885.871114.641000.02489.70235.48
PB Ratio
-144.081.6741.3818.4932.51
P/TBV Ratio
-153.071.7310.2917.0231.69

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
948.34872.63391.91962.37459.24227.99

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-8.4913.100.054.783.541.44
Net Debt / Equity Ratio
-0.91-2.15-1.08-1.56-1.15-1.03
Net Debt / EBITDA Ratio
-0.160.130.440.310.520.72
Net Debt / FCF Ratio
-0.150.130.730.340.580.67
Asset Turnover
-0.010.000.010.010.05
Quick Ratio
6.103.683.764.959.945.89
Current Ratio
6.463.933.945.2510.176.20
Return on Equity (ROE)
1996.40%-197.85%1905.92%-475.31%-263.00%-127.91%
Return on Assets (ROA)
-74.48%-82.52%-135.66%-73.22%-58.51%-52.05%
Return on Capital Employed (ROCE)
-91.10%-106.86%-169.27%-85.15%-65.99%-63.71%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
--731.30%---
Buyback Yield / Dilution
-0.49%-3.36%-27.17%70.62%-5.52%-50.47%
Total Shareholder Return
-0.49%-3.36%-27.17%70.62%-5.52%-50.47%
SEC Filings: 10-K · 10-Q